Product Recalls in Washington

Product recalls affecting Washington — including food, drugs, consumer products, medical devices, and vehicles distributed to Washington. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,805 recalls have been distributed to Washington in the last 12 months.

51,768 total recalls
2,805 in last 12 months

Showing 64616480 of 13,410 recalls

DrugAugust 14, 2018· Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Recalled Item: Diltiazem HCl Extended-release Capsules Recalled by Mylan Institutional,...

The Issue: Failed Impurities/Degradation Specifications; out of specification results...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugAugust 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets Recalled by AVKARE Inc. Due to CGMP Deviations: Carcinogen...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 10, 2018· Westlab Pharmacy, Inc. dba Westlab Pharmacy

Recalled Item: Cyclosporine 1% Human Eye Drops Recalled by Westlab Pharmacy, Inc. dba...

The Issue: Lack of Process Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 10, 2018· Westlab Pharmacy, Inc. dba Westlab Pharmacy

Recalled Item: ADAA Cataract Drops Recalled by Westlab Pharmacy, Inc. dba Westlab Pharmacy...

The Issue: Lack of Process Controls

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 10, 2018· Westlab Pharmacy, Inc. dba Westlab Pharmacy

Recalled Item: Alprostadil 500 mcg/mL Injectable Recalled by Westlab Pharmacy, Inc. dba...

The Issue: Incorrect Product Formulation

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 9, 2018· Orexigen Therapeutics, Inc.

Recalled Item: Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets...

The Issue: Defective Container: Customer complaints of punctures in the bottle.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugAugust 8, 2018· Hetero Labs Limited Unit V

Recalled Item: Camber Pharmaceuticals Recalled by Hetero Labs Limited Unit V Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 8, 2018· Hetero Labs Limited Unit V

Recalled Item: Camber Pharmaceuticals Recalled by Hetero Labs Limited Unit V Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 8, 2018· Akorn, Inc.

Recalled Item: Azelastine HCl Ophthalmic Solution 0.05% Recalled by Akorn, Inc. Due to...

The Issue: Failed Impurities/Degradation Specifications:out-of-specification (OOS)...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugAugust 8, 2018· Hetero Labs Limited Unit V

Recalled Item: Camber Pharmaceuticals Recalled by Hetero Labs Limited Unit V Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 8, 2018· Hetero Labs Limited Unit V

Recalled Item: Camber Pharmaceuticals Recalled by Hetero Labs Limited Unit V Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 7, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Diltiazem HCl Extended-Release Capsules Recalled by Mylan Pharmaceuticals...

The Issue: Failed Impurities/Degradation Specifications: Out of specification test...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugAugust 7, 2018· Mylan Pharmaceuticals Inc.

Recalled Item: Diltiazem HCl Extended-Release Capsules Recalled by Mylan Pharmaceuticals...

The Issue: Failed Impurities/Degradation Specifications: Out of specification test...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugAugust 7, 2018· PD-Rx Pharmaceuticals, Inc.

Recalled Item: Doxycycline Hyclate USP Tablets Recalled by PD-Rx Pharmaceuticals, Inc. Due...

The Issue: Failed Dissolution Specifications: manufacturer West-Ward Pharm Corp....

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 3, 2018· Product Quest Manufacturing LLC

Recalled Item: Finafta Baby Recalled by Product Quest Manufacturing LLC Due to CGMP...

The Issue: CGMP Deviations: products manufactured under conditions that could impact...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 3, 2018· Product Quest Manufacturing LLC

Recalled Item: Rexall Recalled by Product Quest Manufacturing LLC Due to CGMP Deviations:...

The Issue: CGMP Deviations: products manufactured under conditions that could impact...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 3, 2018· Product Quest Manufacturing LLC

Recalled Item: Well at Walgreens Recalled by Product Quest Manufacturing LLC Due to...

The Issue: Subpotent Drug: low out of specification assay results for the octocrylene...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugAugust 3, 2018· Product Quest Manufacturing LLC

Recalled Item: QC Quality Choice Recalled by Product Quest Manufacturing LLC Due to CGMP...

The Issue: CGMP Deviations: products manufactured under conditions that could impact...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 3, 2018· Product Quest Manufacturing LLC

Recalled Item: Premier Value Recalled by Product Quest Manufacturing LLC Due to CGMP...

The Issue: CGMP Deviations: products manufactured under conditions that could impact...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 3, 2018· Product Quest Manufacturing LLC

Recalled Item: Thayers Natural Remedies Recalled by Product Quest Manufacturing LLC Due to...

The Issue: CGMP Deviations: products manufactured under conditions that could impact...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund